Advertisement

Early Evidence Suggests Proton Therapy May Offer Safe, Long-Term Treatment for Hodgkin Lymphoma

Advertisement

Key Points

  • In patients with Hodgkin lymphoma, proton therapy following chemotherapy has a success rate similar to the conventional treatments (ie, intensity-modulated radiation therapy and three-dimensional conformal radiation therapy).
  • Proton therapy following chemotherapy may be a safe alternative to more conventional forms of radiation in patients with Hodgkin lymphoma.

Despite some success in treating patients with Hodgkin lymphoma, many patients may experience late effects of radiation therapy and chemotherapy treatment, including the possible onset of breast cancer or heart disease. A study by Hoppe et al from the University of Florida Proton Therapy Institute reported that the use of proton therapy following chemotherapy in patients with Hodgkin lymphoma has a success rate similar to conventional treatments with a reduction of radiation outside of the target area, potentially reducing the risk of late effects caused by radiation.

The phase II study published in the online edition of the International Journal of Radiation Oncology • Biology • Physics, adds to data supporting the use of proton radiation therapy for positive long-term treatment outcomes. Several retrospective dosimetry studies, measuring the radiation dose in tissue resulting from exposure to direct and/or indirect radiation, have reported the advantages of proton therapy in Hodgkin lymphoma as a way of reducing the radiation dose to the organs at risk, such as the heart, breast, and lungs. However, this study is the first of its kind to track the results of proton therapy treatment in patients with Hodgkin lymphoma.

Proton Therapy Benefits Patients in Study

The study tracked 15 patients between September 2009 and June 2013 with newly diagnosed Hodgkin lymphoma as they received involved-node proton therapy, which specifically targets initially involved lymph node(s), after completing chemotherapy. Further, the study evaluated the radiation dose in the surrounding healthy tissue as a result of proton therapy compared with intensity-modulated radiation therapy and three-dimensional conformal radiation therapy.

The data showed a 3-year relapse-free rate of 93% and a 3-year event-free rate of 87%. No patients developed grade 3 or higher toxicity during follow-up.

“All 15 patients derived benefits from using proton therapy. The results show that the use of protons, as opposed to similar conventional photon therapy, reduced the risk of long-term side effects by reducing or eliminating radiation doses to healthy tissue without compromising the cure rate,” said lead researcher Bradford S. Hoppe, MD, Radiation Oncologist at the University of Florida Proton Therapy Institute and Assistant Professor in the University of Florida College of Medicine Department of Radiation Oncology.

“This study reinforces proton therapy as a safe alternative to the more conventional forms of radiation [intensity-modulated radiation therapy and three-dimensional conformal radiation therapy],” Dr. Hoppe said.

The content in this post has not been reviewed by the American Society of Clinical Oncology, Inc. (ASCO®) and does not necessarily reflect the ideas and opinions of ASCO®.


Advertisement

Advertisement



Advertisement